⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for small cell lung cancer limited stage

Every month we try and update this database with for small cell lung cancer limited stage cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Molecular Analysis and Treatment Options of SCLCNCT05945745
Small-cell Lung...
Small Cell Lung...
Small Cell Lung...
Small Cell Lung...
Small Cell Lung...
Chemotherapy
18 Years - Shanghai Chest Hospital
Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLCNCT03214003
Small Cell Lung...
Radiotherapy
SIB
Standard
18 Years - 70 YearsPeking University Cancer Hospital & Institute
Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLCNCT03214003
Small Cell Lung...
Radiotherapy
SIB
Standard
18 Years - 70 YearsPeking University Cancer Hospital & Institute
Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent ChemoradiotherapyNCT04418648
Small Cell Lung...
Toripalimab
18 Years - 75 YearsSun Yat-sen University
PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC PatientsNCT05651802
Small Cell Lung...
Prophylactic cr...
Thoracic radiot...
Chemotherapy
18 Years - Zhejiang Cancer Hospital
Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLCNCT04189094
Small Cell Lung...
Sintilimab
Etoposide
Cisplatin
radiotherapy
18 Years - Zhejiang Cancer Hospital
Immunotherapy as Second-line in Patient With Small Cell Lung CancerNCT03059667
Small Cell Lung...
Small Cell Lung...
Small Cell Lung...
Atezolizumab
Topotecan
Carboplatin
Etoposide
18 Years - Intergroupe Francophone de Cancerologie Thoracique
A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLCNCT04543890
Small Cell Lung...
Hyperfractionat...
Hypofractionate...
Etoposide
Cisplatin
18 Years - 75 YearsZhejiang Cancer Hospital
Immunotherapy as Second-line in Patient With Small Cell Lung CancerNCT03059667
Small Cell Lung...
Small Cell Lung...
Small Cell Lung...
Atezolizumab
Topotecan
Carboplatin
Etoposide
18 Years - Intergroupe Francophone de Cancerologie Thoracique
Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)NCT04602533
Small Cell Lung...
Durvalumab
standard of car...
18 Years - Johannes Gutenberg University Mainz
Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)NCT04602533
Small Cell Lung...
Durvalumab
standard of car...
18 Years - Johannes Gutenberg University Mainz
Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung CancerNCT01797159
Small-cell Lung...
SCLC
Small Cell Lung...
Hippocampal-spa...
18 Years - 100 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLCNCT04543890
Small Cell Lung...
Hyperfractionat...
Hypofractionate...
Etoposide
Cisplatin
18 Years - 75 YearsZhejiang Cancer Hospital
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: